ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2691Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 111,256 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.19% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 104,624 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.87% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 65,390 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.02% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 69,535 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 4.33% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 280 shares, the number of shares held increased 1.13% compared to the previous period and now represents 0.98% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 38,355 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 1.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 39,234 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 2.07% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 156,648 shares, the number of shares held decreased 1.41% compared to the previous period and now represents 1.18% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 812 shares, the number of shares held decreased 3.03% compared to the previous period and now represents 1.02% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 178,906 shares, the number of shares held increased 1.44% compared to the previous period and now represents 1.97% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 49,997 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 3.5% of the total position.
ARKG Investment Tracker position change: Increased position in Veeva by 730 shares, the number of shares held increased 1.14% compared to the previous period and now represents 1.27% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 170,014 shares, the number of shares held increased 1.58% compared to the previous period and now represents 2.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 172,545 shares, the number of shares held decreased 1.65% compared to the previous period and now represents 1.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 48,864 shares, the number of shares held decreased 2.12% compared to the previous period and now represents 2.73% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 62,665 shares, the number of shares held decreased 0.54% compared to the previous period and now represents 1.79% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 168 shares, the number of shares held increased 0.62% compared to the previous period and now represents 1.03% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 13,546 shares, the number of shares held increased 0.11% compared to the previous period and now represents 2.13% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 163,020 shares, the number of shares held decreased 1.41% compared to the previous period and now represents 5.61% of the total position.
Go to Tiger App to see more news